Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, November 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy: 1 policy source

patent: 13 patents

Readers on

mendeley: 156 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 13 patents that reference this research output.

High affinity human antibodies to human angiopoietin-2

Grant US-10875911-B2

United States of America

29 Dec 2020

Angiopoietin-based interventions for treating cerebral malaria

Grant US-10525106-B2

United States of America

07 Jan 2020

Angiopoietin-based interventions for treating cerebral malaria

Grant US-10251938-B2

United States of America

09 Apr 2019

Angiopoietin-based interventions for treating cerebral malaria

Grant US-9968653-B2

United States of America

15 May 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 9 additional patents.